FMS mutations in myelodysplastic, leukemic, and normal subjects - Wikidata - wikimedia - TriplyDB

FMS mutations in myelodysplastic, leukemic, and normal subjects

FMS mutations in myelodysplastic, leukemic, and normal subjects

http://www.wikidata.org/entity/Q24559066

about

A novel fusion of RBM6 to CSF1R in acute megakaryoblastic leukemia The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: a case-control study Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.Activating point mutations in the common beta subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of beta subunit dimerization and cell type-specific molecules in signalling AML1 interconnected pathways of leukemogenesis c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms The Src-like adaptor protein 2 regulates colony-stimulating factor-1 receptor signaling and down-regulation.Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain An excellent monitoring system for surface ubiquitination-induced internalization in mammals Epstein-Barr virus associated B-cell lymphoma of brain developing in myelodysplastic syndrome with c-kit mutation (Try-557 -->stop).Cbl-mediated K63-linked ubiquitination of JAK2 enhances JAK2 phosphorylation and signal transduction.Cbl and human myeloid neoplasms: the Cbl oncogene comes of age.Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming.Class III receptor tyrosine kinases: role in leukaemogenesis.The process of leukemogenesis Receptor tyrosine kinase mutations in myeloid neoplasms.Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal.Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases.Configuration of the TP53 gene as an independent prognostic parameter of myelodysplastic syndrome.The MAPK ERK5, but not ERK1/2, inhibits the progression of monocytic phenotype to the functioning macrophage.FLT3: ITDoes matter in leukemia.A point mutation in the extracellular domain of KIT promotes tumorigenesis of mast cells via ligand-independent auto-dimerization Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids.Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.Study of p53 in elderly patients with myelodysplastic syndromes by immunohistochemistry and DNA analysis The use of next-generation sequencing in movement disorders Pharmacogenetics of alkylator-associated acute myeloid leukemia.Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.CSF-1R up-regulation is associated with response to pharmacotherapy targeting tyrosine kinase activity in AML cell lines.CSF1R mosaicism in a family with hereditary diffuse leukoencephalopathy with spheroids Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies.Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia.Degradation of activated protein kinases by ubiquitination.The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.Prognostic molecular markers in myelodysplastic syndromes.Receptor tyrosine kinases: from biology to pathology.Molecular and genetic features of myelodysplastic syndromes.

P2860

Q24685013-5642C5CC-552B-4A7A-A201-519FCA6FD159 Q24794951-2D4A36E4-104E-4C1A-975D-D27CE4B4083E Q24794971-512C2817-9124-4C54-BE69-1502C448160F Q26828777-9D1101FA-F943-4173-AB35-6DC4221C4F5C Q27851565-19850609-24E2-4117-9DD3-FCE21DDC4785 Q27852644-568A6085-0A1D-4F6F-8E7E-AA12841BF4F8 Q28117340-66AF77BB-B67E-43A3-8FB3-8C6105FF1652 Q28184349-B6C97C59-BD64-449F-99E1-D6C96122FAED Q28201688-1E86851A-0061-4901-93F3-1B3A4B656A9F Q30158029-9B3C2939-79D4-4B71-A2A5-280198432C4D Q31106485-2B60F3FC-5874-4087-AEC2-5394727D2F32 Q33317260-25D927FD-1AD0-48C3-9BDB-51896C9D41A1 Q33335103-FC7E344F-DEF3-4295-9643-9AE1130A822D Q33870784-41162F47-C957-468E-A371-3604DADC80E8 Q33925815-818EDF67-294E-4F03-8859-ED319145CD1A Q34124396-5F6C3232-6954-44F1-B293-D468F91FD0BA Q34557003-2DB15903-D29A-4B6A-9A1C-34F612D974B5 Q34637442-89DA7C75-9156-4506-8D8F-1F0049108215 Q34655403-9DF0A912-ECEF-4404-B3EC-CF433A16D571 Q34747216-C1BF4701-62F5-478E-B900-3EE33E38D5EE Q35058437-A4C396B3-1874-4593-8224-5045E9FCF8F8 Q35175273-8D6C122B-A314-4895-B48B-AA51AEDF0F41 Q35189282-BFDB464A-41C7-4529-8AC3-70A4FDEE952F Q35217399-B208C5AE-78B5-4ACA-99BF-B1230A4F3A9E Q35596167-116B816C-A321-4576-A511-10B00F961D33 Q35705431-9060E908-F827-4002-B458-E7A4E95ADF24 Q35782919-E2735941-5756-4712-8DED-D874BDE64EBE Q35787871-3C2D8417-D256-453F-B221-A923C0156557 Q35955394-7EE058D5-FB38-46FD-A425-88BBBB4E97AA Q36555916-C117D29F-C8A0-44C7-B1C2-9766B7D20527 Q36591394-834E92C0-BB88-4546-AEEB-EB38E6ECEE58 Q36694605-F180630C-F315-4D2D-A8E3-E9E549AF89AF Q36967706-248F5B0E-2877-48B0-902E-44A21C96080E Q37051428-D8937C84-975E-4237-AFCA-F899BE10B742 Q37183513-17BBD65D-7FA2-43F2-9CA7-C0ED02FB0893 Q37419861-9DDC92D0-0A05-4D65-8E09-D2B68C0B090E Q37728685-14932976-A7A1-43EF-A1A1-4CB6C3B824EC Q37810120-05E47B49-B502-41C7-9B39-BAF9D7F0992F Q37951099-22303038-1859-45E2-A352-8E9ABD994128 Q37972713-A05CAC16-17DB-44D9-8C67-D69F26D4049F

P2860

FMS mutations in myelodysplastic, leukemic, and normal subjects

http://www.wikidata.org/entity/Q24559066

description

1990 nî lūn-bûn

@nan

1990 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

FMS mutations in myelodysplastic, leukemic, and normal subjects

@ast

FMS mutations in myelodysplastic, leukemic, and normal subjects

@en

FMS mutations in myelodysplastic, leukemic, and normal subjects

@nl

type

label

FMS mutations in myelodysplastic, leukemic, and normal subjects

@ast

FMS mutations in myelodysplastic, leukemic, and normal subjects

@en

FMS mutations in myelodysplastic, leukemic, and normal subjects

@nl

prefLabel

FMS mutations in myelodysplastic, leukemic, and normal subjects

@ast

FMS mutations in myelodysplastic, leukemic, and normal subjects

@en

FMS mutations in myelodysplastic, leukemic, and normal subjects

@nl

P1433

Q24559066-8ABFE451-3E03-4918-8E07-BCED8D863493

P1476

Q24559066-D284FD3F-E12C-4F2B-AB1B-00737D023110

P2093

Q24559066-28C20C26-3F0B-4D61-A63A-34271A0504C1

Q24559066-9F388B3C-2E9E-47CB-930A-8143FD7B4B58

Q24559066-C2B34464-2CA9-415D-A8B6-0A9C09EFE6CB

Q24559066-E8687473-FA18-4F20-8416-131298E9BF64

Q24559066-F6100FFB-E6E3-49F4-81F5-B62D5741CE4D

P2860

Q24559066-075A01E7-EAD6-4244-8520-E6789F86D9C9

Q24559066-12056483-52DE-4EE1-8770-5F9D5D17274F

Q24559066-14B24817-42D3-48F3-B9B9-A34A87EE3631

Q24559066-1648EA2F-E992-4A79-9D85-CFC5CABEC665

Q24559066-19267516-5F29-4D34-AE2F-F95BDFFE5AD3

Q24559066-2A36C5D0-F5FA-4F7D-A597-53CD9B84A45C

Q24559066-32CAD8E3-5A2E-402E-8D41-799CD8495453

Q24559066-3CCD4779-77A1-4618-B419-CFC6D9587612

Q24559066-46E4F62A-9052-4024-A574-4CF1CDA05DA8

Q24559066-488A0736-B981-41AF-897F-CBD950A615B9

P304

Q24559066-7D9AA530-0FD9-450F-BAC3-4E9D445F03D0

P31

Q24559066-23F48E5E-F163-4756-922D-B201F43E2367

P356

Q24559066-29D086C0-8BF9-43CC-BF79-BA2142A241E8

P407

Q24559066-2C7FBBA8-A3AD-40F4-8EEE-C1B253C46DDD

P433

Q24559066-B1F520DD-C727-4D37-9420-0260DFA4D40F

P478

Q24559066-B75B3648-77B4-4F10-815C-FF6C421BB337

P577

Q24559066-940C01D4-BC5E-4C37-8A48-5C0A2E147DBD

P5875

Q24559066-AAC5F385-ED7B-40DC-B439-39451D1E1F94

P698

Q24559066-691B8D00-F917-4C86-B6F1-3E630710A3DA

P921

Q24559066-71F3AED3-05F8-435E-9E63-4C99FE72F469

P932

Q24559066-ACBECD43-8B32-4684-AF4D-876CE3DD75FF

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

FMS mutations in myelodysplastic, leukemic, and normal subjects

@en

P2093

A Jacobs

http://www.w3.org/2001/XMLSchema#string

D Oscier

http://www.w3.org/2001/XMLSchema#string

M Worwood

http://www.w3.org/2001/XMLSchema#string

R A Padua

http://www.w3.org/2001/XMLSchema#string

S A Ridge

http://www.w3.org/2001/XMLSchema#string

P2860

DNA sequencing with chain-terminating inhibitors

Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

Proposals for the classification of the myelodysplastic syndromes

Evidence for the involvement of GM-CSF and FMS in the deletion (5q) in myeloid disorders

The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1

Purification of the colony-stimulating factor 1 receptor and demonstration of its tyrosine kinase activity

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group.

Nucleotide sequence of the feline retroviral oncogene v-fms shows unexpected homology with oncogenes encoding tyrosine-specific protein kinases.

Molecular cloning of the c-fms locus and its assignment to human chromosome 5.

P304

1377-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.87.4.1377

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

1990-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20748829

http://www.w3.org/2001/XMLSchema#string

P698

2406720

http://www.w3.org/2001/XMLSchema#string

P921

P932

53478

http://www.w3.org/2001/XMLSchema#string